Inaktiver Wert

Andere Sprachen Generex Biotechnology Corporation OTC Bulletin Board

Aktien

US3714851033

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

2022	Unfreiwillige Petition für Generex Biotechnology Corporation genehmigt	CI
2022	Unfreiwillige Petition gegen Generex Biotechnology Corporation eingereicht	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Motion for Asset Sale Approved for Generex Biotechnology Corporation	19.01.
Motion for Asset Sale Filed by Generex Biotechnology Corporation	01.12.
Motion for Asset Sale Approved for Generex Biotechnology Corporation	13.01.23
Amended Bidding Procedure Approved for Generex Biotechnology Corporation	10.01.23
Involuntary Petition Approved for Generex Biotechnology Corporation	06.06.22
Involuntary Petition Filed Against Generex Biotechnology Corporation	23.04.22
Generex Biotechnology Corporation : Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA	26.07.21
Generex Biotechnology : Material Event (Form 8-K)	23.07.21
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	23.07.21
Generex Biotechnology Corporation Enters into Quality Agreement with PPD Development, L.P	23.07.21
Generex Biotechnology : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Unregistered Sales of Equity Securities (Form 8-K)	21.07.21
GENEREX BIOTECHNOLOGY CORP : Unregistered Sale of Equity Securities (form 8-K)	21.07.21
Generex Biotechnology Corporation announced that it has received $1 million in funding	15.07.21
NuGenerex Immuno-Oncology Secures $535 Million Valuation from World-Class Independent Valuation & Appraisal Firm	22.06.21
GENEREX BIOTECHNOLOGY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21.06.21
Generex Biotechnology Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	21.06.21
GENEREX BIOTECHNOLOGY CORP : Other Events (form 8-K)	12.05.21
Generex Biotechnology : Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services	11.05.21
Generex Biotechnology Corporation Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring Services	11.05.21
Generex Posts Recording of May 6 Shareholder Conference Call Highlighting its Ii-Key COVID Complete Vaccine™ and its Go-Forward Plans for Revenue Producing Assets	10.05.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Generex Biotechnology Corporation OTC Bulletin Board

Aktien

US3714851033

Andere Sprachen

Filter